Items tagged with Advocacy
Unprecedented focus on global public health at UN General Assembly (post with simple image)
WHO urges world leaders to commit to progress on pandemic prevention, preparedness and response and to secure health for all, end TB, and reinvigorate SDGs.
Lancet Commission calls for renewed global response on TB (post with simple image)
Without action, more than 27 million lives could be lost between now and 2050.
Johnson & Johnson and Cepheid must expand access to TB drug and tests (post with simple image)
TB is curable but remains the world’s leading infectious disease killer as pharma corporations stand in the way of affordable medical tools.
Reduced price and increased access to Cepheid’s TB test (post with simple image)
Global Fund, Stop TB Partnership and USAID announce new collaboration with Danaher to reduce price and increase access to Cepheid’s TB test. Five million additional tests can be procured with this lower price.
Nearly all countries “far off track” of meeting TB research targets despite publicly reaffirming commitments at UN (post with simple image)
A sobering new analysis from Treatment Action Group shows that governments failed to meet previous commitments to fund TB research.
At this week’s UN General Assembly High-Level Meeting on TB, the 1/4/6×24 Campaign calls on political leaders to take urgent action for equitable access to shorter, safer TB regimens (post with simple image)
Ahead of the UN General Assembly High-Level Meeting on TB, the 1/4/6×24 Campaign is sounding the alarm that the political declaration commits neither the funding nor the actions needed to expand access to the best-available TB regimens and diagnostics.
World leaders commit to new targets to end TB (post with simple image)
World leaders at the UN High-Level Meeting on TB have approved a Political Declaration with ambitious new targets for the next five years to advance the global efforts towards ending the TB epidemic.
Open letters to Johnson & Johnson requesting equitable access to bedaquiline (post with simple image)
Ukraine, Belarus, Azerbaijan and Moldova demand that Johnson & Johnson take urgent action to improve equitable access to bedaquiline in all countries with a high burden of TB.
Johnson & Johnson confirms intent not to enforce patents for SIRTURO® (bedaquiline) for the treatment of multidrug-resistant TB in 134 low- and middle-income countries (post with simple image)
The decision is intended to assure current and future generic manufacturers that they may manufacture and sell generic versions of SIRTURO® without a concern that the Company will enforce its bedaquiline patents, provided the generic versions of SIRTURO® are of good quality, medically acceptable, and are used only in the 134 low- and middle-income countries.
Johnson & Johnson pricing agreement for critical TB drug still unfairly restricts access in countries where the need is greatest (post with simple image)
Unitaid calls on Johnson & Johnson to drop secondary patents for the drug-resistant TB medicine bedaquiline, and to make negotiated rates with the Stop TB Partnership’s Global Drug Facility available to all countries, regardless of how they purchase drugs.
Page 122 of 127 · Total posts: 0
←First 121 122 123 Last→